Table 2.
Natural history of COVID-19 symptoms and anosmia in patients from a London community and secondary-care population between March 1st and April 1st, 2020
| Total | Community | Admitted | |
|---|---|---|---|
| Patients with resolved COVID-19 symptoms | 114 | 83 | 31 |
| Patients with unresolved COVID-19 symptoms | 13 | 6 | 7 |
| Median duration of COVID-19 symptoms in days (interquartile range) | 12 (11.5) | 10 (8) | 118 (13.5) |
| Patients with resolved anosmia | 49 | 34 | 15 |
| Patients with unresolved anosmia/ongoing hyposmia | 32 | 21 | 11 |
| Median lag for onset of anosmia in days (IQR) | 4 (5) | 3 (3) | 5 (4) |
| Median duration of anosmia in days (IQR) | 8 (16) | 14 (16) | 7 (8.5) |
IQR, interquartile range.